Page 1675 - Clinical Small Animal Internal Medicine
P. 1675
Index 1613
IHD see intermittent hemodialysis feline coronavirus 875 protozoal and protozoa‐like
VetBooks.ir ILAE see International League Against male reproductive system spotted fever and typhus group
intestinal cancers 1287–1292
infections 1019
IL see interleukins; intermediate lobe
Rickettsia 939–940
tumors 1314–1315
Epilepsy
ileoscopy 525–526 mast cell tumors 1364 impetigo 1463
image‐guided sampling 675 melanoma 1347 implantable cardioverter defibrillators
IMHA see immune‐mediated hemolytic oral cavity and salivary (ICD) 204
anemia glands 537, 542 impression smears 1387–1391
immune complex‐mediated papillomaviruses 863 IMRT see intensity‐modulated radiation
glomerulonephritis (ICGN) plasma cell disorders 1245 therapy
1101, 1103, 1106–1107 rabies 894 incidence odds/odds ratios 15–16
immune‐mediated hemolytic anemia immunophenotyping 1224, incidence rates 14–15, 21–22
(IMHA) 1233, 1237 incontinence 1184–1188
chronic enteropathies 634 immunosuppression/immunotherapy indolent ulcer 1504–1505, 1504
clinical decision making atopic dermatitis 1411–1412 inducible nitric oxide synthase
19–23, 20 autoimmune and immune‐ (iNOS) 423
paraneoplastic syndromes mediated skin disease infectious disease
1219–1220 1423–1431, 1425 advantages/disadvantages of
pulmonary thromboembolism 319 bartonellosis 924 diagnostic methods 840
immune‐mediated thrombocytopenia bone and joint tumors 1331 approach to the dermatologic
(ITP) 23, 1220 canine distemper virus 851–852 patient 1376
immune system canine herpesvirus 855–856 bacterial infections 844–845
biology of cancer and cancer canine histiocytic canine inflammatory liver
genetics 1208 disorders 1442–1448 disease 695–696
canine inflammatory liver chronic enteropathies 636 communicating findings 836
disease 696 chronic kidney disease 1170 confirming presence of disease
chronic enteropathies 628 feline coronavirus 875 outbreak 834
critical care setting 351 feline inflammatory liver cutaneous manifestations of systemic
cutaneous manifestations of systemic disease 693 disease 1484–1486
disease 1487–1488 feline leukemia virus 878 descriptive epidemiology
ehrlichiosis and anaplasmosis forebrain disorders 781 834–835, 835
903–905 fungal infections 986–988 disease monitoring and
neuromuscular junction glomerular disease 1106–1107 surveillance 833–834
diseases 804–806 hemangiosarcoma 1343 epidemiology 833–837
oral cavity and salivary glands hemotropic Mycoplasma esophageal and stomach
542–544, 543 927–928 cancers 1283–1284
rectoanal diseases 614, 615 Lyme borreliosis 943 establishing a case definition 834
tularemia 955 melanoma 1349–1351, 1350 establishing an investigation
see also autoimmune and meningoencephalitis team 834
immune‐mediated skin disease; and meningomyelitis fever 434
vaccination 800–801, 800 fluid therapy 356
immunization see vaccination miscellaneous skin forebrain disorders 781–784
immunofluorescence assay (IFA) diseases 1498–1500 formulating and testing
canine distemper virus 852 mycobacteriosis 980 hypotheses 835–836
ehrlichiosis and nocardiosis 980 fungal infections 845–847, 846
anaplasmosis 909–910 nocosomial and multidrug‐resistant gallbladder and extrahepatic biliary
protozoal and protozoa‐like infections 1058 ducts 721–722, 725
infections 1004, 1004, 1006, nonmelanoma skin cancers gastritis and gastric
1008, 1011, 1014 1356, 1357 ulceration 549–553
immunoglobulins 1241–1242, 1428 oral tumors 1255 implementing control and prevention
immunohistochemistry (IHC) papillomaviruses 863 measures 836
canine histiocytic paraneoplastic syndromes 1220 kennels and multicat
disorders 1442–1444 principles of therapy of dermatologic environments 1063–1066
chronic enteropathies 634 diseases 1400 laboratory diagnosis 839–847
